搜尋
Yahoo! 財經
你好!Guest
[ 用戶登入新用戶? ]

Exact Sciences Corporation
(EXAS)

Down 0.16 (4.04%)
3.800
最新價
2010年2月10日 上午 5:00 HKT
買入: N/A昨日收市: N/A
賣出: N/A開市: N/A
今日波幅: N/A

基本資料

其他股份的基本資料:
Exact Sciences Corporation
441 Charmany Drive
Madison, WI 53719
Phone: 608-284-5700
Fax: 608-284-5701
Web Site: http://www.exactsciences.com

 DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Employees (last reported count):4

 REUTERS ABRIDGED BUSINESS SUMMARY 
Exact Sciences Corporation, a molecular diagnostics company, focuses on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Its non-invasive stool-based DNA (sDNA) screening technology includes proprietary and patented methods that isolate and analyze human DNA present in stool to screen for the presence of colorectal pre-cancer and cancer. The company’s principal product includes ColoSure, a non-invasive laboratory developed stool-based DNA testing service for the detection of colorectal cancer in the average-risk population. Exact Sciences Corporation has strategic alliances with Laboratory Corporation of America Holdings, the MAYO Foundation for Medical Education and Research, and Genzyme Corporation. The company was founded in 1995 and is based in Madison, Wisconsin.
Key Statistics
More from Reuters
Expanded Business Description

 COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Exact Sciences Corporation


    More from Reuters
    Reuters offers more in-depth Company Research , Stock Screening , and >Risk Alerts on over 10,000 U.S. Equities.

     REUTERS ABRIDGED FINANCIAL SUMMARY 
    View Financials
    More from Reuters
    Significant Developments - Highlights - Performance - Ratio Comparison


     OFFICERS 
     PayExercised
    Mr. Patrick J. Zenner MBA, 62
    Exec. Chairman and Member of Compensation Committee
    $ 7.00KN/A
    Mr. Kevin T. Conroy , 44
    Chief Exec. Officer, Pres
    N/A N/A
    Mr. Maneesh K. Arora , 41
    Chief Financial Officer and Sr. VP
    N/A N/A
    Dr. Barry M. Berger MD, FCAP,
    Chief Medical Officer
    N/A N/A
    Dr. Graham P. Lidgard Ph.D., 60
    Chief Science Officer and Sr. VP
    N/A N/A
    Dollar amounts are as of 31-Dec-07 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders
    More from Reuters:
    Full List - Bios - Compensation - Options


    加進我的投資組合 加進我的投資組合    寄給朋友 寄給朋友

    資料提供及版權歸於 AASTOCKSDBPower經濟通內幕人 Insiders.hkInteractive Data Real Time Services凱基証券QuamnetTelekurs (USA) INC
    用戶意見 | 私隱政策 | 服務條款 | 免責條款
    Copyright © 2010 Yahoo! Hong Kong Limited. All rights reserved. 版權所有 不得轉載
    免責聲明:以上資料由雅虎香港有限公司的資料提供夥伴(如AASTOCKS、DBPower、經濟通、內幕人Insiders.hk、Interactive Data Real Time Services、凱基証券、Quamnet 和 Telekurs (USA) INC)提供,僅作參考之用,雅虎香港有限公司及資料提供夥伴對以上資訊的準性和可靠性不能亦不會作任何保證或承擔,並對基於該等資料或有關的錯漏或延誤而作出的任何決定或導致的損失概不負責。
    權益披露包括: 法團大股東之交易, 個人大股東之交易, 董事或最高行政人員之交易,及董事或最高行政人員買賣其上市公司的子公司或付屬公司之交易。
    所有股票報價及認股證報價均延遲最少十五分鐘。